Cancer Family
Skin Neoplasm
CI-CAN-00000051Explore in graph →
Non-malignant347 active trials14 approved drugs74 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000051Explore in graph →
Clinical trials
1,424 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03693937 | A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC) | completed | — | 776 | Sensus HealthcareINDUSTRY | 1 | Jul 5, 2019 | clinicaltrials |
| NCT01159067 | Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload | terminated | Phase 2 | 1 | City of Hope Medical CenterOTHER | 1 | Jun 18, 2019 | clinicaltrials |
| NCT01408043 | Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma | terminated | N/A | 25 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 14, 2019 | clinicaltrials |
| NCT01017185 | Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions | completed | Phase 1 | 28 | Takara Bio Inc.INDUSTRY | 1 | May 23, 2019 | clinicaltrials |
| NCT00476905 | Spectral Diagnosis of Cutaneous Malignancy | completed | — | 350 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT01800838 | Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma | completed | Phase 1 | 11 | Kevin Cooper MDOTHER | 1 | May 16, 2019 | clinicaltrials |
| NCT01258855 | Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery | completed | Phase 2 | 84 | National Cancer Institute (NCI)NIH | 1 | May 10, 2019 | clinicaltrials |
| NCT01988831 | Efficacy of Propranolol Treatment to Prevent Melanoma Progression | suspended | Phase 2 | 450 | University Hospital, GenevaOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT03094273 | Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi | completed | — | 138 | NYU Langone HealthOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT02352428 | Skin Cancer Screening Education Study(SCSES) | unknown | N/A | 113 | Association of Dermatological Prevention, GermanyOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT03210337 | A Phase2 of A-101 Topical Solution in Subjects With Common Warts | completed | Phase 2 | 157 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | May 1, 2019 | clinicaltrials |
| NCT02123511 | Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy | completed | Phase 2 | 34 | Mayo ClinicOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT03373305 | Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas | withdrawn | Phase 1 | 0 | City of Hope Medical CenterOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT00993512 | Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer | completed | Phase 1 | 19 | PCI Biotech ASINDUSTRY | 1 | Apr 29, 2019 | clinicaltrials |
| NCT01060319 | A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies | withdrawn | — | 0 | Stanford UniversityOTHER | 1 | Apr 18, 2019 | clinicaltrials |
| NCT02735356 | Topical Itraconazole in Treating Patients With Basal Cell Cancer | completed | Early Phase 1 | 9 | Jean Yuh TangOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT03278028 | A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts | completed | Phase 2 | 159 | Aclaris Therapeutics, Inc.INDUSTRY | 1 | Apr 9, 2019 | clinicaltrials |
| NCT02900248 | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice(N1) | terminated | — | 23 | CureOneOTHER | 1 | Apr 2, 2019 | clinicaltrials |
| NCT02704039 | Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin | completed | — | 239 | University of Texas at AustinOTHER | 1 | Mar 13, 2019 | clinicaltrials |
| NCT02690948 | Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer | completed | Phase 1 / Phase 2 | 16 | Anne ChangOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT02760160 | Dietary Prevention of Photodamage in Skin With Grapes | completed | N/A | 18 | University of Alabama at BirminghamOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT02813902 | A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors | withdrawn | Phase 1 | 0 | Massachusetts General HospitalOTHER | 0 | Mar 8, 2019 | clinicaltrials |
| NCT00710489 | Potential Research Study Participant Registry | completed | — | 265 | University of California, DavisOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT02668887 | Employment and Quality of Life in Patients With Malignant Melanoma | completed | — | 221 | Fachklinik Hornheide an der Universität MünsterOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT03822988 | ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS(PADAONCODERM) | unknown | — | 150 | Central Hospital, Nancy, FranceOTHER | 1 | Jan 30, 2019 | clinicaltrials |
| NCT02303041 | Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma | terminated | Phase 2 | 10 | Anne ChangOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT02941744 | A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases(ipniv) | completed | Phase 1 / Phase 2 | 56 | Universitair Ziekenhuis BrusselOTHER | 1 | Jan 24, 2019 | clinicaltrials |
| NCT01093586 | Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies | completed | Phase 2 | 14 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03604666 | Follow-up of Elderly Patients in Ambulatory Surgery(PAPA) | unknown | — | 320 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT02872909 | Randomized Comparison of Low and Conventional Irradiance PDT for Skin Cancer | completed | N/A | 50 | Sally IbbotsonOTHER | 0 | Jan 4, 2019 | clinicaltrials |
| NCT03219671 | Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS) | unknown | Phase 2 | 20 | Alona ZerOTHER | 1 | Dec 26, 2018 | clinicaltrials |
| NCT02061449 | Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma | terminated | Phase 1 | 3 | NYU Langone HealthOTHER | 1 | Dec 24, 2018 | clinicaltrials |
| NCT02556463 | A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors | terminated | Phase 1 | 53 | MedImmune LLCINDUSTRY | 3 | Dec 19, 2018 | clinicaltrials |
| NCT02327390 | Ex Vivo-Activated Lymph Node Lymphocytes in Treating Patients With Stage IIIC-IV Melanoma | terminated | Phase 1 | 3 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT00038025 | A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies | completed | Phase 2 | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 16, 2018 | clinicaltrials |
| NCT02542124 | NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) | unknown | Phase 2 | 10 | Neumedicines Inc.INDUSTRY | 1 | Nov 16, 2018 | clinicaltrials |
| NCT00788775 | Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma | completed | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 15, 2018 | clinicaltrials |
| NCT01764607 | Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma | terminated | Phase 2 | 1 | University of FloridaOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT01108094 | Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas | completed | Phase 2 | 29 | Stanford UniversityOTHER | 1 | Nov 13, 2018 | clinicaltrials |
| NCT01460875 | Recombinant Interferon Alfa-2b in Treating Patients With Melanoma | completed | N/A | 34 | William CarsonOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT02654821 | Study With T-cel Receptor Gene Therapy in Metastatic Melanoma(TCR) | unknown | Phase 1 / Phase 2 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT00027586 | Imatinib Mesylate in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00038376 | Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies | completed | Phase 2 | 56 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 29, 2018 | clinicaltrials |
| NCT00958074 | Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma | terminated | Phase 2 | 11 | University of WashingtonOTHER | 1 | Oct 18, 2018 | clinicaltrials |
| NCT02270645 | Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser(BCC) | completed | N/A | 12 | University of MiamiOTHER | 1 | Oct 2, 2018 | clinicaltrials |
| NCT03673917 | Cosmetology Students and Skin Cancer | completed | N/A | 310 | University of ArkansasOTHER | 1 | Sep 20, 2018 | clinicaltrials |
| NCT01590732 | Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma | completed | Phase 1 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT02602067 | 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients(Tenatumomab) | terminated | Phase 1 | 2 | sigma-tau i.f.r. S.p.A.INDUSTRY | 2 | Sep 18, 2018 | clinicaltrials |
| NCT01663571 | STAT3 in T Cells: At The Crossroads of Inflammation and Cancer | terminated | — | 35 | NYU Langone HealthOTHER | 1 | Sep 17, 2018 | clinicaltrials |
| NCT03362138 | Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions(NNCD) | unknown | — | 80 | Assuta Hospital SystemsOTHER | 1 | Sep 13, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Jul 5, 2019source: clinicaltrials